Phosphorylated/activated HER2 (P-HER2) as a marker of clinical resistance to single agent taxane chemotherapy for meta-static breast cancer (MBC) Meeting Abstract


Authors: Modi, S.; DiGiovanna, M. P.; Lu, Z.; Moskowitz, C.; Panageas, K. S.; Van Poznak, C.; Hudis, C. A.; Norton, L.; Tan, L.; Stern, D. F.; Carter, D.; Seidman, A. D.
Abstract Title: Phosphorylated/activated HER2 (P-HER2) as a marker of clinical resistance to single agent taxane chemotherapy for meta-static breast cancer (MBC)
Meeting Title: 94th Annual Meeting of the American Association for Cancer Research (AACR)
Keywords: clinical resistance
Journal Title: Proceedings of the American Association for Cancer Research Annual Meeting
Volume: 44
Meeting Dates: 2003 Jul 11-14
Meeting Location: Washington, DC
ISSN: 0197-016X
Publisher: American Association for Cancer Research  
Date Published: 2003-07-01
Start Page: 320
End Page: 320
Language: English
ACCESSION: BCI:BCI200300475177
PROVIDER: biosis
Notes: Meeting abstract: 1635 -- 94th Annual Meeting of the American Association for Cancer Research -- Washington, DC, USA -- July 11-14, 2003 -- Source: Biosis